| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 3.983 | 21.937 | 26.269 | 29.962 | 34.280 | 38.775 | 39.226 | 48.670 | 57.916 |
| Total Income - EUR | - | 3.983 | 21.937 | 26.269 | 29.962 | 34.280 | 40.291 | 39.226 | 48.670 | 57.916 |
| Total Expenses - EUR | - | 1.165 | 6.153 | 8.709 | 13.402 | 11.934 | 19.315 | 21.900 | 33.186 | 30.084 |
| Gross Profit/Loss - EUR | - | 2.817 | 15.784 | 17.560 | 16.559 | 22.346 | 20.975 | 17.326 | 15.484 | 27.832 |
| Net Profit/Loss - EUR | - | 2.698 | 15.126 | 16.778 | 15.661 | 21.373 | 20.037 | 16.641 | 15.132 | 26.130 |
| Employees | - | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Georgy Medgyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 126 | 0 | 4.655 | 3.440 | 3.161 | 30.014 | 24.549 | 13.725 | 11.404 |
| Current Assets | - | 3.761 | 16.528 | 12.297 | 23.824 | 20.692 | 8.139 | 7.853 | 25.186 | 21.290 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 1.213 | 1.616 | 2.072 | 4.357 | 2.688 | 2.515 | 6.489 | 4.402 | 0 |
| Cash | - | 2.548 | 14.913 | 10.226 | 19.467 | 18.004 | 5.625 | 1.364 | 20.784 | 21.290 |
| Shareholders Funds | - | 2.742 | 15.170 | 16.821 | 27.098 | 21.414 | 20.078 | 16.682 | 25.294 | 26.170 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 1.285 | 1.537 | 230 | 318 | 2.522 | 18.176 | 16.108 | 14.002 | 8.062 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Georgy Medgyn Srl